After being found effective over longer durations with smaller doses, this study found that nipocalimab infusions resulted in a tolerable safety profile and remained effective even in shorter ...
Newborns, particularly premature infants, are highly vulnerable during intravenous infusion treatments due to their low immunity, inability to express discomfort, and fragile veins. Chemical ...
A randomized phase 2 trial of combretatstatin A4 phosphate (CA4P) in combination with paclitaxel and carboplatin to evaluate safety and efficacy in subjects with advanced imageable malignancies No ...
Intravenous thrombolysis remains a standard treatment for acute ischemic stroke within 4.5 hours after onset. Vascular reocclusion may occur after intravenous thrombolysis and may be preventable with ...
DENVER — Administering multiple intravenous (IV) infusions is common in the critical care environment, but it increases the potential for errors. Researchers with the HumanEra project at University ...
LUBBOCK, Texas (KCBD) - Raider Rehab is an IV infusion service founded by first responders in Lubbock. The medical director, Dr. Beau McCrory, initially created the service to help people recover from ...
Ocrevus is an intravenous (IV) infusion given every 6 months to manage certain types of multiple sclerosis (MS) and clinically isolated syndrome (CIS). Some more common side effects are respiratory ...
Shannon Wood Rothenberg walked into her annual physical feeling fine. But more than a year later, she's still paying the price. Routine bloodwork from that spring 2018 medical visit suggested ...
During the two decades I’ve had Crohn’s disease, I’ve been on lots of different medications. But an infusion — a biologic that’s given intravenously — can seem particularly daunting, especially if you ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results